This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanders, L. A.
Right arrow Articles by van de Winkel, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanders, L. A.
Right arrow Articles by van de Winkel, J. G.

 Previous Article  |  Next Article 

Infect. Immun., Jan 1995, 73-81, Vol 63, No. 1
Copyright © 1995, American Society for Microbiology

Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils

LA Sanders, RG Feldman, MM Voorhorst-Ogink, M de Haas, GT Rijkers, PJ Capel, BJ Zegers and JG van de Winkel
Department of Immunology, University Hospital for Children, Het Wilhelmina Kinderziekenhuis, Utrecht, The Netherlands.

Human immunoglobulin G (IgG) Fc receptor IIa (Fc gamma RIIa; CD32) is expressed on phagocytes, triggers phagocytosis, and represents the sole Fc receptor for IgG (Fc gamma R) capable of interaction with IgG2, the main IgG subclass induced in response to bacterial capsular polysaccharides. The two genetically determined structurally different allotypes of human Fc gamma RIIa, the products of the Fc gamma RIIa- R131 and IIa-H131 alleles, have functionally different reactivities with human IgG2. In humans, the Fc gamma RIIa-H131 allotype is known to interact efficiently with complexed human IgG2, whereas the IIa-H131 allotype does so only poorly. This polymorphism may therefore have implications for IgG2-mediated phagocytosis of encapsulated bacteria and susceptibility to bacterial infections. Phagocytosis of IgG2- opsonized bacteria by homozygous Fc gamma RIIa-R/R131, heterozygous IIa- H/R131, and homozygous IIa-H/H131 polymorphonuclear cells (PMN) was compared. A higher phagocytic capacity of IgG2-opsonized group B type III streptococci by PMN of homozygous H/H131 individuals compared with PMN from homozygous R/R131 individuals was observed (P = 0.001), while heterozygous IIa-H/R131 PMN showed intermediate phagocytosis. In this model system, IgG2-mediated phagocytosis was independent of the Fc gamma RIIIb-NA1/NA2 allelic polymorphism.


This article has been cited by other articles:

  • Endeman, H., Cornips, M. C. A., Grutters, J. C., van den Bosch, J. M., Ruven, H. J. T., van Velzen-Blad, H., Rijkers, G. T., Biesma, D. H. (2009). The Fc{gamma} Receptor IIA-R/R131 Genotype Is Associated with Severe Sepsis in Community-Acquired Pneumonia. CVI 16: 1087-1090 [Abstract] [Full Text]  
  • Richards, J. O., Karki, S., Lazar, G. A., Chen, H., Dang, W., Desjarlais, J. R. (2008). Optimization of antibody binding to Fc{gamma}RIIa enhances macrophage phagocytosis of tumor cells. Molecular Cancer Therapeutics 7: 2517-2527 [Abstract] [Full Text]  
  • Bossuyt, X., Moens, L., Van Hoeyveld, E., Jeurissen, A., Bogaert, G., Sauer, K., Proesmans, M., Raes, M., De Boeck, K. (2007). Coexistence of (Partial) Immune Defects and Risk of Recurrent Respiratory Infections. Clin. Chem. 53: 124-130 [Abstract] [Full Text]  
  • Kinane, D.F., Hart, T.C. (2003). GENES AND GENE POLYMORPHISMS ASSOCIATED WITH PERIODONTAL DISEASE. CROBM 14: 430-449 [Abstract] [Full Text]  
  • Gemmell, E., Yamazaki, K., Seymour, G.J. (2002). DESTRUCTIVE PERIODONTITIS LESIONS ARE DETERMINED BY THE NATURE OF THE LYMPHOCYTIC RESPONSE. CROBM 13: 17-34 [Abstract] [Full Text]  
  • Kobayashi, T., Yamamoto, K., Sugita, N., van Spriel, A. B., Kaneko, S., van de Winkel, J. G. J., Yoshie, H. (2001). Effective In Vitro Clearance of Porphyromonas gingivalis by Fc{alpha} Receptor I (CD89) on Gingival Crevicular Neutrophils. Infect. Immun. 69: 2935-2942 [Abstract] [Full Text]  
  • Lakshman, R, Finn, A (2001). Neutrophil disorders and their management. J. Clin. Pathol. 54: 7-19 [Abstract] [Full Text]  
  • van Schie, R. C. A. A., Wilson, M. E. (2000). Evaluation of Human Fcgamma RIIA (CD32) and Fcgamma RIIIB (CD16) Polymorphisms in Caucasians and African-Americans Using Salivary DNA. CVI 7: 676-681 [Abstract] [Full Text]  
  • Neeleman, C., Geelen, S. P. M., Aerts, P. C., Daha, M. R., Mollnes, T. E., Roord, J. J., Posthuma, G., van Dijk, H., Fleer, A. (1999). Resistance to Both Complement Activation and Phagocytosis in Type 3 Pneumococci Is Mediated by the Binding of Complement Regulatory Protein Factor H. Infect. Immun. 67: 4517-4524 [Abstract] [Full Text]  
  • Myhr, K.-M., Raknes, G., Nyland, H., Vedeler, C. (1999). Immunoglobulin G Fc-receptor (Fc{gamma}R) IIA and IIIB polymorphisms related to disability in MS. Neurology 52: 1771-1771 [Abstract] [Full Text]  
  • Pirofski, L.-a., Casadevall, A. (1998). Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host. Clin. Microbiol. Rev. 11: 1-26 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»